Evogene (NASDAQ:EVGN – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Thursday, August 22nd. Parties interested in registering for the company’s conference call can do so using this link.
Evogene (NASDAQ:EVGN – Get Free Report) last issued its earnings results on Thursday, May 23rd. The biotechnology company reported ($0.80) earnings per share (EPS) for the quarter. Evogene had a negative net margin of 233.66% and a negative return on equity of 70.96%. The company had revenue of $4.19 million for the quarter.
Evogene Trading Up 2.6 %
NASDAQ EVGN opened at $4.05 on Wednesday. Evogene has a 1-year low of $3.79 and a 1-year high of $10.40. The firm’s fifty day simple moving average is $5.52 and its 200-day simple moving average is $6.86. The company has a market capitalization of $166.92 million, a PE ratio of -8.80 and a beta of 1.40.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on Evogene
About Evogene
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.
Recommended Stories
- Five stocks we like better than Evogene
- Dividend Capture Strategy: What You Need to Know
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- The Most Important Warren Buffett Stock for Investors: His Own
- Lowe’s Stock: Hold Now, Buy it When it Dips
- What is Forex and How Does it Work?
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.
